Follow
Tine Schytte
Tine Schytte
Odense Universitetshospital
Verified email at dadlnet.dk
Title
Cited by
Cited by
Year
High-dose versus standard-dose twice-daily thoracic radiotherapy for patients with limited stage small-cell lung cancer: an open-label, randomised, phase 2 trial
BH Grønberg, KT Killingberg, Ø Fløtten, OT Brustugun, K Hornslien, ...
The Lancet Oncology 22 (3), 321-331, 2021
1062021
First clinical experiences with a high field 1.5 T MR linac
AS Bertelsen, T Schytte, PK Møller, F Mahmood, HL Riis, KL Gottlieb, ...
Acta Oncologica 58 (10), 1352-1357, 2019
1062019
Stereotactic body radiation therapy versus conventional radiation therapy in patients with early stage non-small cell lung cancer: an updated retrospective study on local …
SS Jeppesen, T Schytte, HR Jensen, C Brink, O Hansen
Acta Oncologica 52 (7), 1552-1558, 2013
852013
Locoregional control of non-small cell lung cancer in relation to automated early assessment of tumor regression on cone beam computed tomography
C Brink, U Bernchou, A Bertelsen, O Hansen, T Schytte, SM Bentzen
International Journal of Radiation Oncology* Biology* Physics 89 (4), 916-923, 2014
842014
Radiation dose response of normal lung assessed by Cone Beam CT–a potential tool for biologically adaptive radiation therapy
A Bertelsen, T Schytte, SM Bentzen, O Hansen, M Nielsen, C Brink
Radiotherapy and Oncology 100 (3), 351-355, 2011
672011
Delineation of whole heart and substructures in thoracic radiation therapy: National guidelines and contouring atlas by the Danish Multidisciplinary Cancer Groups
MLH Milo, BV Offersen, T Bechmann, ACP Diederichsen, CR Hansen, ...
Radiotherapy and Oncology 150, 121-127, 2020
652020
Time evolution of regional CT density changes in normal lung after IMRT for NSCLC
U Bernchou, T Schytte, A Bertelsen, SM Bentzen, O Hansen, C Brink
Radiotherapy and Oncology 109 (1), 89-94, 2013
602013
Online adaptive radiotherapy potentially reduces toxicity for high-risk prostate cancer treatment
RL Christiansen, L Dysager, CR Hansen, HR Jensen, T Schytte, ...
Radiotherapy and Oncology 167, 165-171, 2022
562022
Efficacy and safety of immune checkpoint inhibitors in a Danish real life non-small cell lung cancer population: a retrospective cohort study
B Bjørnhart, KH Hansen, TL Jørgensen, J Herrstedt, T Schytte
Acta Oncologica 58 (7), 953-961, 2019
502019
ESTRO-ACROP recommendations on the clinical implementation of hybrid MR-linac systems in radiation oncology
S Corradini, F Alongi, N Andratschke, D Azria, O Bohoudi, L Boldrini, ...
Radiotherapy and Oncology 159, 146-154, 2021
452021
Prediction of lung density changes after radiotherapy by cone beam computed tomography response markers and pre-treatment factors for non-small cell lung cancer patients
U Bernchou, O Hansen, T Schytte, A Bertelsen, A Hope, D Moseley, ...
Radiotherapy and Oncology 117 (1), 17-22, 2015
422015
Cardiac toxicity and radiation dose to the heart in definitive treated non-small cell lung cancer
T Schytte, O Hansen, T Stolberg-Rohr, C Brink
Acta Oncologica 49 (7), 1058-1060, 2010
362010
Pemetrexed safety and pharmacokinetics in patients with third-space fluid
NJ Dickgreber, JB Sorensen, LG Paz-Ares, TK Schytte, JE Latz, ...
Clinical Cancer Research 16 (10), 2872-2880, 2010
332010
Impact of comprehensive geriatric assessment on quality of life, overall survival, and unplanned admission in patients with non-small cell lung cancer treated with stereotactic …
SS Jeppesen, LE Matzen, C Brink, R Bliucukiene, S Kasch, T Schytte, ...
Journal of geriatric oncology 9 (6), 575-582, 2018
322018
Heterogeneous FDG-guided dose-escalation for locally advanced NSCLC (the NARLAL2 trial): design and early dosimetric results of a randomized, multi-centre phase-III study
DS Møller, TB Nielsen, C Brink, L Hoffmann, CM Lutz, MD Lund, ...
Radiotherapy and Oncology 124 (2), 311-317, 2017
322017
Pattern of loco-regional failure after definitive radiotherapy for non-small cell lung cancer
T Schytte, TB Nielsen, C Brink, O Hansen
Acta Oncologica 53 (3), 336-341, 2014
312014
Acute esophagitis for patients with local–regional advanced non small cell lung cancer treated with concurrent chemoradiotherapy
Y Pan, C Brink, M Knap, AA Khalil, CH Nyhus, T McCulloch, B Holm, Y Wu, ...
Radiotherapy and Oncology 118 (3), 465-470, 2016
292016
Nationwide survival benefit after implementation of first-line immunotherapy for patients with advanced nsclc—Real world efficacy
MT Mouritzen, A Carus, M Ladekarl, P Meldgaard, AWM Nielsen, ...
Cancers 13 (19), 4846, 2021
282021
A randomized phase II trial of concurrent chemoradiation with two doses of radiotherapy, 60 Gy and 66 Gy, concomitant with a fixed dose of oral vinorelbine in locally advanced …
O Hansen, MM Knap, A Khalil, CH Nyhus, T McCulloch, B Holm, C Brink, ...
Radiotherapy and Oncology 123 (2), 276-281, 2017
272017
Inhomogeneous dose escalation increases expected local control for NSCLC patients with lymph node involvement without increased mean lung dose
TB Nielsen, O Hansen, T Schytte, C Brink
Acta Oncologica 53 (1), 119-125, 2014
242014
The system can't perform the operation now. Try again later.
Articles 1–20